Artificial Pancreas: first clinical trials in Argentina
"The first clinical trials using an Artificial Pancreas (AP) in Latin America have been defined in 2 stages. The first stage was carried out in November 2016 with the UVA controller (developed by the Center for Diabetes Technology and already clinically tested), and the second will be performed...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Ponencias en Congresos acceptedVersion |
Lenguaje: | Inglés |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | http://ri.itba.edu.ar/handle/123456789/1763 |
Aporte de: |
id |
I32-R138-123456789-1763 |
---|---|
record_format |
dspace |
spelling |
I32-R138-123456789-17632022-12-07T14:13:41Z Artificial Pancreas: first clinical trials in Argentina Sánchez-Peña, Ricardo Colmegna, Patricio Grosembacher, Luis Breton, Marc De Battista, Hernán Garelli, Fabricio Belloso, Waldo H. Campos-Náñez, Enrique Simonovich, Ventura Beruto, Valeria Scibona, Paula Cherñavvsky, Daniel ORGANOS ARTIFICIALES PANCREAS ENSAYOS CLINICOS DIABETES CONTROL EN MODO DESLIZANTE INSULINA GLUCOSA "The first clinical trials using an Artificial Pancreas (AP) in Latin America have been defined in 2 stages. The first stage was carried out in November 2016 with the UVA controller (developed by the Center for Diabetes Technology and already clinically tested), and the second will be performed during the first semester of 2017 with the ARG (Automatic Regulation of Glucose) algorithm (developed by ITBA, UNQ, and UNLP in Argentina). Both tests are based on the DiAs (Diabetes Assistant) from the UVA, and are performed in the HIBA on 5 patients with Type 1 Diabetes Mellitus (T1DM), for 36 hours. For the first stage, Open-Loop (OL) insulin boluses were applied before meals and patient's physical activity was included. On the other hand, for the second stage, patients will not be involved in physical activity, but no OL insulin boluses will be injected before meals. In this work, experimental results from the first stage with the UVA controller, and preliminary results with the ARG control algorithm tested on the UVA/Padova simulator are presented. Due to the final paper deadline, the experimental results from the second stage are not included here, but will be presented at the IFAC World Congress." 2019-09-20T15:55:52Z 2019-09-20T15:55:52Z 2017-07 Ponencias en Congresos info:eu-repo/semantics/acceptedVersion 2405-8963 http://ri.itba.edu.ar/handle/123456789/1763 en info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ifacol.2017.08.1151 info:eu-repo/grantAgreement/Fundación Cellex/ES. Barcelona info:eu-repo/grantAgreement/UVA/US. Virginia application/pdf Argentina |
institution |
Instituto Tecnológico de Buenos Aires (ITBA) |
institution_str |
I-32 |
repository_str |
R-138 |
collection |
Repositorio Institucional Instituto Tecnológico de Buenos Aires (ITBA) |
language |
Inglés |
topic |
ORGANOS ARTIFICIALES PANCREAS ENSAYOS CLINICOS DIABETES CONTROL EN MODO DESLIZANTE INSULINA GLUCOSA |
spellingShingle |
ORGANOS ARTIFICIALES PANCREAS ENSAYOS CLINICOS DIABETES CONTROL EN MODO DESLIZANTE INSULINA GLUCOSA Sánchez-Peña, Ricardo Colmegna, Patricio Grosembacher, Luis Breton, Marc De Battista, Hernán Garelli, Fabricio Belloso, Waldo H. Campos-Náñez, Enrique Simonovich, Ventura Beruto, Valeria Scibona, Paula Cherñavvsky, Daniel Artificial Pancreas: first clinical trials in Argentina |
topic_facet |
ORGANOS ARTIFICIALES PANCREAS ENSAYOS CLINICOS DIABETES CONTROL EN MODO DESLIZANTE INSULINA GLUCOSA |
description |
"The first clinical trials using an Artificial Pancreas (AP) in Latin America have been defined in 2 stages. The first stage was carried out in November 2016 with the UVA controller (developed by the Center for Diabetes Technology and already clinically tested), and the second will be performed during the first semester of 2017 with the ARG (Automatic Regulation of Glucose) algorithm (developed by ITBA, UNQ, and UNLP in Argentina). Both tests are based on the DiAs (Diabetes Assistant) from the UVA, and are performed in the HIBA on 5 patients with Type 1 Diabetes Mellitus (T1DM), for 36 hours. For the first stage, Open-Loop (OL) insulin boluses were applied before meals and patient's physical activity was included. On the other hand, for the second stage, patients will not be involved in physical activity, but no OL insulin boluses will be injected before meals. In this work, experimental results from the first stage with the UVA controller, and preliminary results with the ARG control algorithm tested on the UVA/Padova simulator are presented. Due to the final paper deadline, the experimental results from the second stage are not included here, but will be presented at the IFAC World Congress." |
format |
Ponencias en Congresos acceptedVersion |
author |
Sánchez-Peña, Ricardo Colmegna, Patricio Grosembacher, Luis Breton, Marc De Battista, Hernán Garelli, Fabricio Belloso, Waldo H. Campos-Náñez, Enrique Simonovich, Ventura Beruto, Valeria Scibona, Paula Cherñavvsky, Daniel |
author_facet |
Sánchez-Peña, Ricardo Colmegna, Patricio Grosembacher, Luis Breton, Marc De Battista, Hernán Garelli, Fabricio Belloso, Waldo H. Campos-Náñez, Enrique Simonovich, Ventura Beruto, Valeria Scibona, Paula Cherñavvsky, Daniel |
author_sort |
Sánchez-Peña, Ricardo |
title |
Artificial Pancreas: first clinical trials in Argentina |
title_short |
Artificial Pancreas: first clinical trials in Argentina |
title_full |
Artificial Pancreas: first clinical trials in Argentina |
title_fullStr |
Artificial Pancreas: first clinical trials in Argentina |
title_full_unstemmed |
Artificial Pancreas: first clinical trials in Argentina |
title_sort |
artificial pancreas: first clinical trials in argentina |
publishDate |
2019 |
url |
http://ri.itba.edu.ar/handle/123456789/1763 |
work_keys_str_mv |
AT sanchezpenaricardo artificialpancreasfirstclinicaltrialsinargentina AT colmegnapatricio artificialpancreasfirstclinicaltrialsinargentina AT grosembacherluis artificialpancreasfirstclinicaltrialsinargentina AT bretonmarc artificialpancreasfirstclinicaltrialsinargentina AT debattistahernan artificialpancreasfirstclinicaltrialsinargentina AT garellifabricio artificialpancreasfirstclinicaltrialsinargentina AT bellosowaldoh artificialpancreasfirstclinicaltrialsinargentina AT camposnanezenrique artificialpancreasfirstclinicaltrialsinargentina AT simonovichventura artificialpancreasfirstclinicaltrialsinargentina AT berutovaleria artificialpancreasfirstclinicaltrialsinargentina AT scibonapaula artificialpancreasfirstclinicaltrialsinargentina AT chernavvskydaniel artificialpancreasfirstclinicaltrialsinargentina |
_version_ |
1765660867339223040 |